Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: translating research into policy.

@article{Madhi2012IntroductionOP,
  title={Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: translating research into policy.},
  author={Shabir A Madhi and Cheryl Cohen and Anne von Gottberg},
  journal={Vaccine},
  year={2012},
  volume={30 Suppl 3},
  pages={
          C21-7
        }
}
In April 2009, South Africa was the first African country to introduce pneumococcal polysaccharide-protein conjugate vaccine (PCV) into its public immunization program. This review summarizes studies on pneumococcal epidemiology and PCV undertaken in South Africa, which contributed to the process of advocating for the inclusion of PCV into the public immunization program. Surveillance prior to the introduction of 7-valent PCV (PCV-7) indicated that 70% (418/593) of invasive pneumococcal disease… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 13 CITATIONS

Effectiveness of 7-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in HIV-Infected and -Uninfected Children in South Africa: A Matched Case-Control Study

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2014
VIEW 3 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

In- and Out-of-hospital Mortality Associated with Seasonal and Pandemic Influenza and Respiratory Syncytial Virus in South Africa, 2009–2013

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND